SEC Form 4 · accession 0001493152-17-004280
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeff Frelick
Officer — Chief Operating Officer
Period of report
May 27, 2016
Accepted (ET)
Apr 21, 2017 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.05 | May 27, 2016 | A | 269,145 | A | — | May 26, 2026 | Common Stock | 269,145 | 1,326,204 | D |
Explanation of responses
- F1On May 27, 2016, the Reporting Person was granted 269,145 stock options, 1/3 of the shares subject to the option vest on each anniversary of the Vesting Commencement Date, subject to the option holder's Continuous Service (as defined in the Plan) on each vesting date, provided the Reporting Person is still providing services to the Issuer on the respective date.